Synthetic

Global Market for Botanical Ingredients to Progress at a 7.3% CAGR from 2024 to 2034, reaching US$ 374.84 Billion: Future Market Insights, Inc.

Retrieved on: 
Mercoledì, Maggio 1, 2024

NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global botanical ingredient market is slated to progress at a CAGR of 7.3%. This will elevate the market size from US$ 185.91 billion to US$ 374.84 billion from 2024 to 2034. The growing healthcare, cosmetic, and food and beverage markets leverage the demand for botanical ingredients.

Key Points: 
  • This increasing inclination towards botanical ingredients is anticipated to ignite a surge in demand, thereby propelling market growth.
  • Key drivers include the recognized therapeutic properties and medicinal benefits associated with botanical ingredient products, which continue to captivate consumer interest and drive market dynamics.
  • NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global botanical ingredient market is slated to progress at a CAGR of 7.3%.
  • This will elevate the market size from US$ 185.91 billion to US$ 374.84 billion from 2024 to 2034.

Global Carotenoid Industry Report 2024: Analysis, Size, Share, Growth, Trends, and Forecast to 2031 - Market Set to Grow Amidst Rising Health Concerns and Demand Surge in the Food Industry - ResearchAndMarkets.com

Retrieved on: 
Lunedì, Aprile 29, 2024

The global carotenoid market is poised for substantial growth, driven by an array of factors ranging from rising health concerns to expanding applications across various industries.

Key Points: 
  • The global carotenoid market is poised for substantial growth, driven by an array of factors ranging from rising health concerns to expanding applications across various industries.
  • The prevalence of cardiovascular diseases has emerged as a key driver influencing the global carotenoid market.
  • As health concerns related to immunity, brain function, and digestive health escalate, there's a growing preference for fortified and functional food products.
  • The food industry remains a significant consumer of carotenoids, driven by the increasing demand for functional and fortified food products.

Global Chloroprene Rubber Industry Research Report 2023-2030 - Neoprene Rubber Sheets Present Compelling Opportunities for Comprehensive Spectrum of Industrial Applications - ResearchAndMarkets.com

Retrieved on: 
Martedì, Aprile 23, 2024

Chloroprene rubber, also known as Neoprene, finds application across various industries due to its unique properties.

Key Points: 
  • Chloroprene rubber, also known as Neoprene, finds application across various industries due to its unique properties.
  • The types of chloroprene rubber and their production methods are outlined, alongside structural variations in polychloroprene grades, contributing to diverse applications.
  • Additionally, the Chloroprene Rubber - Global Key Competitors Percentage Market Share in 2023 provides a snapshot of market dominance among major players.
  • The Chloroprene Rubber market in the U.S. is estimated at 44.5 Thousand Metric Tons in the year 2023.

MSC CRUISES AND CHANTIERS DE L'ATLANTIQUE MARK TWO IMPORTANT MILESTONES FOR NEW WORLD CLASS SHIPS

Retrieved on: 
Martedì, Aprile 9, 2024

MSC World America floats out and enters final phase of construction in preparation for naming ceremony in Miami on April 9, 2025

Key Points: 
  • MSC World America floats out and enters final phase of construction in preparation for naming ceremony in Miami on April 9, 2025
    GENEVA, April 9, 2024 /PRNewswire/ -- MSC Cruises and Chantiers de l'Atlantique marked two important milestones today in the construction of the innovative World Class ships, MSC World America and MSC World Asia, during a press conference at Seatrade Cruise Global in Miami.
  • Following the format of the other World Class ships that pay homage to different continents, MSC World Asia will symbolize the global nature of MSC Cruises.
  • Laurent Castaing, General Manager, Chantiers de l'Atlantique commented, "We are very proud to begin construction on MSC World Asia.
  • MSC World America and MSC World Asia, as with all new MSC Cruises ships, will be fitted with shore power connectivity as standard.

CredibleX and zypl.ai Form Strategic Partnership Harnessing Generative AI to Empower 20,000 SMEs

Retrieved on: 
Venerdì, Marzo 29, 2024

Flagship credit decision software from zypl.ai (the "zypl.score") enhances CredibleX's instantaneous risk assessment and pre-approval engine for SMEs.

Key Points: 
  • Flagship credit decision software from zypl.ai (the "zypl.score") enhances CredibleX's instantaneous risk assessment and pre-approval engine for SMEs.
  • The uniqueness of zypl.score lies in a 'no data' AI approach centered on generation of synthetic data to complement other data sources for fintechs such as CredibleX.
  • Founder and CEO of zypl.ai , Azizjon Azimi, commented, "Synthetic data is at the core of generative AI revolution sweeping through the world of finance.
  • zypl.ai is pioneering generative AI in lending through application of proprietary synthetic data.

Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute

Retrieved on: 
Martedì, Aprile 9, 2024

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the signing of an international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute (Mātai), on behalf of the Tū Wairua Project.

Key Points: 
  • VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the signing of an international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute (Mātai), on behalf of the Tū Wairua Project.
  • This agreement marks Optimi's first supply deal to New Zealand, a significant milestone for the company's global expansion efforts.
  • Under the terms of the agreement, Optimi will provide Mātai with a quantity of its validated GMP Full Spectrum Natural Psilocybin extract.
  • Further, the agreement includes tracked stability of the extract, ensuring the highest standards of GMP quality and compliance.

Sexual Health Supplement Market Size, Share & Trends Analysis Report 2024: Natural Ingredients Lead Market Amid Preference for Organic Products - Global Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Martedì, Marzo 26, 2024

As per King's College London, ED is estimated that by 2025, 322 million men worldwide are expected to be affected by it.

Key Points: 
  • As per King's College London, ED is estimated that by 2025, 322 million men worldwide are expected to be affected by it.
  • Government-supported sexual health programs indeed have a significant impact on the market.
  • These programs help to increase awareness about sexual health issues, promote safe sex practices and encourage people to take proactive steps to maintain their sexual health.
  • For instance, Australia Department of Health has "Healthysexual" program, which raise awareness about sexual health.

BCC Research Reveals Top Ten Suppliers of Synthetic Biology Technology in 2024

Retrieved on: 
Martedì, Aprile 2, 2024

BOSTON, April 2, 2024 /PRNewswire/ -- According to the latest BCC Research study, the demand for Top Ten Suppliers of Synthetic Biology Technology is estimated to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 10.8% during the forecast period of 2023-2028.

Key Points: 
  • With growing interest and investment from countries worldwide, synthetic biology promises sustainable solutions and transformative applications across industries.
  • Furthermore, it provides forecasts for 2028, allowing stakeholders to anticipate future trends and opportunities in the synthetic biology sector.
  • Growth in Synthetic Biology Foundries: Synthetic biology foundries serve as collaborative hubs for research and development, providing access to shared resources, expertise, and standardized biological parts.
  • Increasing Research and Development Investment by Pharma Companies: Pharmaceutical companies are increasingly recognizing the potential of synthetic biology and investing in research and development efforts.

Hydrochloric Acid Market Size to Grow by USD 978.77 million, 5.72% YOY market growth in 2023-2024, Technavio

Retrieved on: 
Giovedì, Marzo 14, 2024

The food segment, valued at USD 689.47 million in 2018, drives significant growth in the hydrochloric acid market.

Key Points: 
  • The food segment, valued at USD 689.47 million in 2018, drives significant growth in the hydrochloric acid market.
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global hydrochloric acid market.
  • Expansion of hydrochloric acid facilities, like SGL Carbon's unit delivery to Travancore-Cochin Chemicals Ltd., drives market growth, enabling companies to enhance their market presence and offer a wider product range, boosting the global hydrochloric acid market.
  • Substitutes like emerald-safe acid, phosphoric acid, sodium bisulfate, and trisodium phosphate pose challenges to hydrochloric acid market growth.

Bitfarms Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Giovedì, Marzo 7, 2024

TORONTO, Ontario and BROSSARD, Québec, March 07, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (Nasdaq/TSX: BITF), a global Bitcoin vertically integrated company, reported its financial results for the fourth quarter and year ended December 31, 2023. All financial references are in U.S. dollars.

Key Points: 
  • - Achieved debt-free goal in February 2024, enhancing financial flexibility -
    TORONTO, Ontario and BROSSARD, Québec, March 07, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (Nasdaq/TSX: BITF), a global Bitcoin vertically integrated company, reported its financial results for the fourth quarter and year ended December 31, 2023.
  • Increased hashrate by 7% to 6.5 EH/s at December 31, 2023, through the installation of 2,300 miners, compared to 6.1 EH/s at the end of Q3 2023.
  • Received $11 million in proceeds during December 2023 and $6 million in proceeds during 2024 from exercise of warrants issued in the November 2023 private placement.
  • Initiated the Synthetic HODL™ strategy with the purchase of 135 long-dated BTC call options held by the Company as of December 31, 2023.